Phacotrabeculectomy using collagen matrix implant (Ologen® ) versus mitomycin C: a prospective randomized controlled trial.

Aleksandra WlaźAgnieszka Wilkos-KucAgnieszka Rozegnał-MadejTomasz Żarnowski

Published in: Acta ophthalmologica (2019)

Ologen (OLO) provides similar surgical outcomes in phacotrabeculectomy compared with adjunctive MMC. It may be a new, safe and effective alternative to MMC for combined phacoemulsification and trabeculectomy surgery.

Keyphrases

randomized controlled trial
minimally invasive
coronary artery bypass
study protocol
surgical site infection
soft tissue
wound healing
cataract surgery
percutaneous coronary intervention